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ABSTRACT
The usual assessment instruments for the diagnosis of
dementia are often difficult to use when evaluating the
disorder among individuals with mental retardation.

This

study investigates whether a modified method based on
Visser et al. (1997) can identify a dementing process.
Ninety individuals diagnosed with severe and profound
mental retardation were studied.

One half of the

participants were diagnosed with Down’s syndrome.

The

participants were equally assigned to one of three groups
based on perceived risk for dementia.
prevalence design was used.

A differential

Both cross sectional and

longitudinal analyses were utilized in this study.

Results

indicate that the Visser et al. (1997) method is effective
in identifying dementia.

Differences between syndrome and

risk of dementia groups will be discussed.

v

Introduction
A significant growth in the elderly population with
mental retardation (MR) has been noted in recent years (Deb
& Janicki, 1995; Janicki, 1994; World Health Organization,
2000).

With this increase, there is a greater proportion

of older persons who develop age related changes affecting
their cognitive, physical, emotional and adaptive
functioning (Cherry, Matson & Paclawsky, 1997; Kapell et
al., 1998).

These physical differences include failing

senses, lessened attentiveness, declining agility,
difficulties with mobility, reduced resistance to disease,
difficulty in recovering from illness and injury, decreased
stamina, depression and anxiety (Anderson, 1993; Evenhuis
et al., 2001; Moss et al., 1993; Williams, 1995).
Increases in the prevalence of age associated psychiatric
diseases such as Alzheimer’s disease and other dementias
have also been noted.

Researchers have shown that

individuals with mental retardation, particularly those
diagnosed with Down’s syndrome, are at an even greater risk
for dementia than the general population (Burns, 1992;
Zigman, Silverman & Wisniewski, 1996).
Several types of dementia have been identified (i.e.,
Alzheimer’s disease, vascular dementia, frontal lobe
dementia, subcortical dementia and dementia due to HIV or

1

other general medical conditions).

Some forms of the

disorder are reversible (i.e., dementia caused by
hypothyroidism, drug induced dementia)(Coffey & Cummings,
1994), therefore careful assessment is important to
distinguish irreversible dementia from reversible dementia
or dementia due to a treatable condition (Kaplan, Sadock, &
Grebb, 1994).

Best practices for the assessment of

dementia among individuals in the general population using
clinical interview, physical exams, and neurological
testing are clearly established and have been conducted for
many years (Coffey & Cummings, 1994).

However, the

standard of care in diagnosis of dementia among individuals
with mental retardation is less clear.

The diagnosis of

dementia in persons with developmental disabilities,
especially in the early stages, is made difficult by the
lack of reliable and standardized criteria and diagnostic
procedures and the trouble of detecting declines against
the already impaired background of developmental disability
(Aylward, Burt, & Thorpe, 1997).

Thus far, the DSM-IV

(APA, 1994) does not provide any information regarding how
to diagnose aging individuals with dementia and mental
retardation.

Perhaps this state of affairs can be

attributed to standard methods of dementia assessment
(i.e., cognitive evaluations, mental status examinations,
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and neuropsychological tests) that appear to be
inappropriate to diagnose persons who have presented with
cognitive delays since childhood (Haveman, Maaskant & von
Schrojenstein, 1994).

Therefore, researchers have begun to

address the issue of diagnosing dementia in individuals
with developmental delays.
Aging in the Developmentally Disabled
The number of individuals that comprise the “elderly
population” is rapidly on the rise (Janicki, Dalton,
Henderson & Davidson, 1999). According to the 2000 US
Census, there are approximately 35 million people age 65
years or older.

This dramatic increase in life expectancy

can be attributed to advances in medicine, public health,
science, education and technology (World Health
Organization, 2000).
Additionally, owing to more readily available
supportive services to individuals with mental retardation
(MR), a much greater proportion of persons with
developmental disabilities are reaching old age (Bittles et
al., 2002; Das & Mishra, 1995).

For instance, persons with

Down’s syndrome had a life expectancy of less than 10 years
in 1929, but with advances in cardiac care and surgical
procedures as well as the availability of general community
health care systems, the life expectancies of these
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individuals have significantly increased (Zigman, Schupf,
Haverman & Silverman, 1995).

Over 40% of live-born Down’s

infants now survive 60 years (Holland, 1999; Yang,
Rasmussen & Friedman, 2002).

The life expectancies of non-

Down’s syndrome persons with MR have dramatically changed
too.

The average age of death for persons with

intellectual disabilities in 1931 was 22 years.

This age

had increased to 59 years by 1976 and to 66.1 years by 1993
(Janicki et al., 1999).

Researchers estimate that,

worldwide, there are as many as 60 million persons who
currently have some level of developmentally related
cognitive impairment (World Health Organization, 2000) and
there are between 200,000 and 500,000 older adults with MR
in the United States (Janicki & Dalton, 2000).

This older

age group will likely double by the year 2025
(Rehabilitation Research and Training Center, 1995).

In

fact, some researchers believe that this “old age” MR
population could reach anywhere between 700,000 to
4,000,000 in the next 20 to 30 years (Silverman et al,
1998).

As these survival rates are gradually approaching

that of the general population, researchers have begun to
focus on age-related health conditions (e.g., physical and
functional changes) among persons with MR.
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Physiological Changes
Researchers have found that the combination of mental
retardation and aging may create additional difficulties
for an individual (LeBlanc & Matson, 1997). Campbell and
Herge (2000) advocate that individuals with MR often
experience a need for additional support due to
physiological and psychological changes associated with
aging.

Common age related physical changes that are

experienced by both the general and developmentally
disabled populations include hearing and visual impairment,
decreased muscle mass and flexibility, and increased
incidence of arthritis, hypertension, heart disease,
diabetes, and osteoporosis (Anderson, 1993; Evenhuis et
al., 2001; Janicki & Dalton, 1998; Moss et al., 1993).
Although these conditions are common to both the
developmentally disabled and the general populations,
individuals with mental retardation have a higher incidence
of death, disease, and disability.

For instance, persons

with mental retardation have been identified as a
“population at risk” because of their poor nutrition
decisions and sedentary lifestyle (Petitti & Campbell,
1991).

Although researchers have found that a third of all

Americans are overweight, obesity among individuals with
mental retardation (particularly females) is even higher
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(US Department of Health and Human Services, 2002).

In

fact, close to half of all people with developmental delays
are overweight (Special Olympic Report, 2001).

The

prevalence of obesity increases among individuals with
Down’s syndrome.

Prasher and Chung (1996) found that 52%

of their participants who were diagnosed with Down’s
syndrome were clinically obese.

Braunschweig and

colleagues (2004) reported that 89% of Down’s syndrome
participants in their study on nutrition were overweight or
obese.

The high levels of excess fat found in people with

developmental disabilities expose them to a higher risk for
many different types of disease associated with obesity.
Researchers have also noted that individuals with mental
retardation are at risk for various diseases (e.g.,
vascular disease, diabetes, hypertensive encephalopathy,
etc.) that result from physical inactivity (Rimmer, 1994).
Researchers have noted that some underlying
characteristics and commonalities typical to individuals
with mental retardation may also have adverse effects on
their health.

For example, individuals with cognitive

disabilities may have difficulty accessing emergency health
services (Spreat & Conroy, 2001).

Persons with

communication deficits are likely to have difficulty
communicating with health care providers (Moss, 1995).
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Also, researchers have found that people with mental
retardation are more likely to be prescribed medication
than individuals in the general population (Kumar &
Brecher, 1999; Young & Hawkins, 2002).

If these

individuals, rather than their caretakers, are responsible
for following their medication regime, rates of medication
non-compliance due to forgetfulness increases drastically
(Torr & Chiu, 2002).

Also, people with a long life history

of taking certain medications (e.g., anticonvulsants,
neuroleptics) are at a higher risk of developing secondary
conditions (e.g., osteoporosis, tardive dyskinesia)
(Zubenko & Sunderland, 2000).

Finally, several

disabilities have been found to be associated with their
primary diagnosis and syndromes (e.g., Down’s syndrome is
associated with a high incidence of thyroid disorder,
cardiac myopathy, and senile dementia of the Alzheimer’s
type).
Psychological Changes
Similarly to physical health, there are also
psychological issues related to aging.

Historically, many

professionals believed that persons with mental retardation
were incapable of developing emotional problems because of
their lack of “proper ego strength” (Reiss, Levitan, &
Szyszko, 1982).

Practitioners assumed that odd or strange
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behaviors in persons with developmental disabilities were
simply due to the individual’s cognitive limitations.

The

term “diagnostic overshadowing” was coined in 1982 because
mental retardation was said to “overshadow” the symptoms of
psychological disturbance (Reiss, 1994; Reiss, Levitan, &
Szyszko, 1982).
Experts in the field have made great strides in the
past two decades in identifying and diagnosing mental
illness in persons with mental retardation.

As a result,

it has been well documented that individuals with
developmental delays are susceptible to the full range of
emotional and personality disorders (Davidson et al., 1994;
Matson & Barrett, 1993; Reiss, 1994). Additionally, the
data gathered suggests that the prevalence of these
disorders in the mentally retarded population is higher
than that of the general population (Dudley, Ahlgrim-Delzel
& Calhoun, 1999; Matson & Sevin, 1994; Moss et al., 1997;
Rojahn & Tasse, 1996).

Prevalence rates of psychopathology

ranging from 10 to 60% percent have been reported
(Borthwick-Duffy, 1994; Davidson et al., 1994; Jacobson,
1999; Matson & Barrett, 1994).

Despite the awareness of

high rates of co-morbid psychiatric conditions among
individuals with MR, researchers continue to show that
behavioral and emotional difficulties are less likely to be
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accurately acknowledged compared to disorders of persons of
average intelligence (Jopp & Keys, 2001).

White et al.

(1995) estimated that people with MR could expect a 19
percent drop in diagnostic accuracy and mental health
treatment recommendations in contrast to persons with
comparable symptoms who do not have other disabilities.
Although attempts to accurately diagnose individuals
with developmental disabilities and co-morbid psychiatric
problems continue to be substandard, researchers have
demonstrated that the rate of psychopathology among persons
with MR remains stable throughout their life span.

Cherry,

Matson, and Packlawskyj (1997) investigated the prevalence
of psychopathology in individuals with severe and profound
mental retardation and found that the frequency of
disorders was comparable for younger and older adults but
older adults showed longer duration and/or greater severity
ratings than did younger adults. The mental health problems
prevalent in older individuals with mental retardation are
consistent with those commonly found among aging persons of
normal intelligence (i.e., anxiety, phobias, and
depression) (Harper & Wadsworth, 1990; McNellis, 1997;
Rojahn, Warren, & Ohringer, 1994).

Researchers have

hypothesized that these psychiatric conditions can result
from physiological changes, medical conditions, long term
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pharmaceutical use, or changes in living situation or
lifestyle (Moss et al., 1997).

In addition to high rates

of mood, anxiety, and adjustment disorders, researchers
have noted an increase in the prevalence of age-associated
psychiatric disorders among persons with mental
retardation.

One such condition is dementia associated

with old age.
Dementia
Dementia is a syndrome where progressive deterioration
in cognitive abilities is sufficiently severe to interfere
with the individual’s usual social or occupational
functioning or their level of personal adjustment (APA,
1994).

This condition is neurologically based and requires

the presence of memory problems plus one of the following:
aphasia (difficulty in expressing thoughts as spoken
words), apraxia (difficulty in carrying out simple,
directed acts), agnosia (difficulty in interpreting
familiar faces or other well-known objects), and
disturbances in executive functioning (the ability to plan
and organize).

Eventually, this problem has dramatic

effects on how well a person is able to care for
him/herself.

An estimated 5-15% of people 65 years of age

and older are affected by a dementing disorder (Kaplan,
Sadock, & Grebb, 1991; Riley, 1999).
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Researchers have

found that several risk factors are associated with
dementia.

These variables include a family history of

dementia, low educational level, previous head trauma,
cardiovascular disease, stroke, diabetes, apolipoprotein E4 allele and previous major depressive episode (Ravaglia,
2002; Sliwinski, Buschke, Stewert, & Masur, 1997).
Most adults with mental retardation are at the same
risk for dementia as are older adults in the general
population (McNellis, 1997; Zigman et al., 2004). Thus far,
the only particular risk factor uniquely identified among
people with mental retardation is Down’s syndrome (Dalton &
Janicki, 1999).

Researchers have found that people with

Down’s syndrome have significantly higher rates of dementia
of the Alzheimer’s type (Holland, Hon, Hubert & Stevens,
2000; Zigman, Silverman & Wisniewski, 1996) and prevalence
increases in an exponential fashion past age 50.
Approximately 25% of adults with Down’s syndrome age 40 to
49 years, approximately 55% of those age 50 to 59 and about
75% of adults age 60 years and older show the behavioral
symptoms of dementia (Zigman, Schupf & Haveman, 1997).
Although not every aging individual with Down’s
syndrome goes on to show clinical manifestations of
dementia (Devenney, Silverman, Hill, Jenkins, Sersen, &
Wisniewski, 1996), upon autopsy, virtually all adults with
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Down’s syndrome over the age of 40 show some evidence of
the neuropathology associated with Alzheimer’s disease
(Mann, 1993).

For instance, these individuals demonstrate

deposition of beta-amyloid in diffuse and neuritic plaques
and intracellular neurofibrillary tangles (Royston et al.,
1999).

This phenomenon appears to be due to the

triplication of the genes for beta-amyloid precursor
protein (B-APP), located on the proximal part of the long
arm of chromosome 21 (Rumble et al., 1989; Schupf, 2002).
Thus far, it is not clear what effect, if any, possible
risk factors as seen in the general population have on
people with Down’s syndrome (Zigman, Schupf & Haveman,
1997).
Although Alzheimer’s disease is the most common and
most researched form of dementia, dementing disorders are a
heterogeneous group of conditions.

Their etiology,

neurological substrate, disease course, and treatment can
vary greatly (Coffey & Cummings, 1994).
of dementia are outlined in DSM-IV.

Twelve categories

They are Dementia of

the Alzheimer’s type, Vascular Dementia, Dementia due to
HIV Disease, Dementia due to Head Trauma, Dementia due to
Parkinson’s Disease, Dementia due to Huntington’s Disease,
Dementia due to Pick’s Disease, Dementia due to
Creuitzfeldt-Jakob Disease, Substance Induced Persisting
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Dementia, Dementia due to Multiple Etiologies, and Dementia
due to Other Medical Condition (APA, 1994). Several types
of dementia will be discussed next.
Alzheimer’s Disease
Alzheimer’s disease is the most common form of
dementia – an illness associated with old age that impairs
intellectual functions (e.g., memory, orientation,
concentration, language, perception, executive
functioning)(Schofield & Mayeux, 1998).

This disorder is a

slow and progressive, degenerative disorder of the brain
that eventually results in diminished brain function and
death.

According to prevalence data, approximately 100,000

victims die and 360,000 new cases are diagnosed each year
(Small et al., 1997).

Researchers estimate that by 2050,

14 million Americans will have this disease (Cummings &
Cole, 2002).

As mentioned, Alzheimer’s disease is an age-

associated disorder but it is not a part of normal aging.
The disease usually begins later in life (late onset –
after age 60); however, it may affect persons as young as
30 years of age (early onset).

Early onset AD results in

about 5-10% of all cases (Cummings & Cole, 2002) and
typically has a much faster course and progression of
deterioration.
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In the early stages of AD, the symptoms may be subtle.
New or recent memory is typically impaired first, and the
individual may find it hard to learn and retain new
information. Eventually, older or distant memory also is
lost. Next, other symptoms may appear, including aphasia,
apraxia, agnosia, and disturbances in executive functioning
(Grabowski & Damasio, 1997).

In practical terms,

individuals with early AD commonly misplace things,
frequently repeat statements, have trouble finding names
for familiar objects, get lost on familiar routes, and lose
interest in things they previously enjoyed.

However,

despite all of these intellectual problems, Lowenstein
(1990) found that many people with early Alzheimer's
disease continue to be able to eat, bathe, dress and groom
themselves as usual without assistance.
Unfortunately, psychiatric symptoms (personality
changes, irritability, anxiety, and depression) also may
occur, and these may cause serious problems in
relationships with family and friends (Balestreri,
Grossberg, & Grossberg, 2000; Hargrave, Stoeklin, Haan, &
Reed, 2000).

Personality changes have not been well

specified and thus, have often gone unrecognized.

However,

in recent years, it has become more widely known that some
dementias can cause changes to an individual’s core
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personality and social-affective functioning.

Researchers

have demonstrated that personality change is a significant
predictor of dementia, independent of cognition and
functional status.

Smith-Gamble et al. (2002) assessed the

predictive value of caregiver reports of changes in
personality on incident dementia and Alzheimer’s disease.
Subjects with changes in personality had approximately
twice the odds of having dementia as subjects with no
change in personality.
As Alzheimer's disease progresses to its middle and
late stages, there may be delusions (irrational beliefs,
especially about being persecuted or having one's
belongings stolen) and hallucinations (false sensations —
seeing, hearing, smelling, tasting or being touched by
something that isn't really there). The patient also may
become aggressive or may begin to wander away from home if
left alone (Riley, 1999). In the final stages of AD, a
person can no longer function without assistance. Most
people in this stage no longer understand language, they no
longer recognize family members, and they can no longer
perform basic activities of daily living such as eating,
dressing, and bathing (Ballard et al., 2001).
The rate that AD advances is different for each
person.

If AD develops rapidly, it is likely to continue
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to progress rapidly.

If the disease has been slow to

progress, it will likely continue on a slow course.

The

duration of the illness may often vary from 3 to 20 years.
The assessment of dementia will soon be discussed but it is
important to note that the diagnosis of Alzheimer’s is
always a diagnosis of exclusion.

It is made based on

characteristic symptoms and by excluding the other causes
of dementia.

The diagnosis of Alzheimer’s disease can only

be confirmed by microscopic examination of a sample of
brain tissue after death (Rogan & Lippa, 2002).
Vascular Dementia
Vascular dementia (VD) is the second most common cause
of dementia, accounting for approximately 20% of all cases
alone and up to another 20% of cases in combination with
Alzheimer’s disease (Pantoni & Inzitari, 2002).

VD is not

a single disease but a group of syndromes associated with
problems in circulation of blood to the brain (cerebravascular disease).

Some subtypes of VD include: (1) multi-

infarct dementia, (2) VD due to strategic single infarct,
(3) VD due to lacunar lesions, (4) VD due to hemorrhagic
lesions, and (5) Binswanger disease.
VD is characterized by uneven impairment in cognitive
functioning and “patchy” performance on neuropsychological
measures (Jefferson et al., 2002). For instance,
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individuals often demonstrate preserved ability on some
domains but impaired performance on others depending on the
site of the infarct or infarcts (Coffey & Cummings, 1994).
Unlike Alzheimer’s disease, the onset of cognitive
impairment is often abrupt and a “stepwise” decline in
cognitive functioning is typically observed as the disease
progresses, with each step representing the occurrence of
another vascular event.

VD usually affects people between

the ages of 60 and 75 years and is slightly more common in
men than women (Alexopoulos, 2003).

Individuals who have

had a stroke are at increased risk for vascular dementia.
In fact, researchers have demonstrated that the prevalence
of dementia is nine times greater in patients who have had
a stroke than in controls.

One year after a stroke,

approximately 25% of patients develop new onset dementia.
Within four years following a stroke, the relative risk of
incident dementia is 5.5 times more likely for these
individuals than for persons who do not have a history of
stroke

(Madureira, Guerreiro, & Ferro, 2001).

Frontal Lobe Dementia
Frontal Lobe Dementia (FLD) is the name given to any
dementia caused by damage to the frontal lobe portion of
the brain.

This part of the brain is known to govern mood,

behavior, judgment, and self-control. FLD includes Pick’s
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disease, but can be caused by other disorders.

Like

Alzheimer’s disease, Pick’s disease dementia causes a
progressive and irreversible decline in a person’s
abilities (Litvan, 2001).

From the onset of the disease,

life expectancy is 2 to 15 years, with an average of 6 to
12 years.

The first symptoms are typically psychological

and behavioral problems.

In fact, the diagnosis is often

suspected to be a psychiatric illness.

Individuals with

FLD demonstrate deterioration of social skills and changes
in personality early in the course of the illness yet they
lack insight into the effects of their behaviors (e.g.,
show insensitivity to others, emotional blunting,
behavioral disinhibition) (Kertesz, 2000).

The individual

often becomes “obsessional” in these early stages,
repeatedly washing hands, observing little rituals, or
insisting that everything is in order (Worthington, 1996).
FLD is also characterized by prominent language
abnormalities.

For instance, the individual may begin

using pat phrases repeatedly and excessively, lack
spontaneous speech, and demonstrate a decrease in
vocabulary.

Eventually, the individual’s dialogue is

unintelligible and they may become completely mute by the
end of the disease (Hodges, 2001).
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Pick’s Disease can affect both men and women and it
typically begins affecting people between 40 and 65 years
of age (Riley, 1999).

As with Alzheimer’s disease, the

cause cannot be determined in most cases; however there are
strong genetic components in certain families.

A mutation

on chromosome 17 has been identified and this genetic
component has been described as affecting 20 to 50% of
people with Pick’s disease (Bird, 1998).
Subcortical Dementias
The subcortical dementias are a group of disorders
characterized by primary dysfunction in the subcortical
areas of the brain.

These dementing conditions lead to

motor dysfunction, speech impairment, memory dysfunction,
executive disorders, and disturbances in mood and
personality (Markesberry, ed., 1998).

Subcortical dementia

occurs with extrapyramidal syndromes such as Parkinson’s
disease, Wilson’s disease, progressive supranuclear palsy,
and Huntington’s disease.

Although there is often a

general decline in intellectual processes over time, this
decline is usually much less severe than in other dementing
disorders.

Parkinson’s and Huntington’s diseases will be

briefly described.
Parkinson’s Disease.

Parkinson’s disease is a slow,

progressive neurological condition characterized by tremor,
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rigidity, bradykinesia, and postural instability.

Dementia

is noted in 20 to 60% of these cases (Aarsland et al.,
2001).

Cognitive and motoric slowing, executive

dysfunction, and impairment in memory retrieval that is
often exacerbated by depression characterize dementia
associated with this disease (Ebmeier, Calder, Crawford, &
Stewart, 1990).
Huntington’s Disease.

Huntington’s disease is an

inherited, progressive, degenerative disease of cognition,
emotion, and movement.

This condition is usually diagnosed

in the late 30’s or early 40’s but may begin as early as
age 4 or as late as age 85.

Onset is often noted to have

changes in behavior and personality (inclusive of
depression, irritability, and anxiety).

Some individuals

present with abnormalities of movement that resemble
increased fidgeting and later progress to the
characteristic “generalized choreothatosis”.

Difficulty

with memory retrieval, executive functioning, and judgment
are common (Paulsen et al., 2001).

Disorganized speech and

psychotic features are sometimes present.

Late in the

disease, marked ventricular dilation consistent with
advanced cerebral atrophy (a.k.a., “boxcar ventricles”) may
be seen on structural brain imaging.
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Clinical Evaluation of Dementia
For a diagnosis of dementia, current criteria in the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV), require evidence of decline from
previous levels of functioning and impairment in multiple
cognitive domains, not solely memory (APA, 1994).

In order

to do this, clinicians have used a combination of clinical
interviews, medical evaluations, and neuropsychology
measures to detect cognitive and memory changes within the
general population.

These methods will be discussed next.

Clinical Interview
A person’s medical and psychosocial history is an
important part of the dementia evaluation.

Taking a

thorough history involves gathering information from the
individual, as well as the person’s family members and
friends. Careful questioning is required to elicit clues to
the presence of functional and cognitive impairment
(Zelinski, Gilewski & Schaie, 1993). Questions should be
asked about forgetfulness and orientation. Information
about the individual’s daily functioning should also be
obtained. For example, it is important to ask questions
about the individual’s ability to do activities like take
care of their hygiene, prepare meals, pay bills, remember
appointments, take medications, and travel out of the
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neighborhood (APA Presidential Task Force, 1997). An
informant can be very helpful in providing information
about the person's symptoms, such as when the symptoms were
first noticed, how quickly they developed, and whether they
have continued to get worse. The interview must review the
individual’s past medical, social, educational, and
vocational histories; whether there is a history of
dementia in the family; and whether there have been any
recent unusual events in the person's life.

Any

significant exposure to alcohol, medications, and other
possible toxins must also be considered (Brooke, 2002).
Physical Exam and Laboratory Results
Current DSM-IV criteria require evidence of impairment
that interferes with the person’s previous level of social
and occupational functioning.

However, because medications

and various medical disorders may have adverse effects on
an individual’s baseline functioning, a thorough assessment
for chronic disease processes and a medication review is
necessary to rule out specific treatable causes of
dementia. Disorders found to cause symptoms of dementia
include hearing or vision deficits, hypothyroidism, vitamin
B12 deficiency and depression (Rogan & Lippa, 2002). These
disorders are relatively easy to detect therefore
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appropriate laboratory tests, physical examinations, and
psychological tests should be administered.
Laboratory tests recommended for the diagnostic workup of dementia include a complete blood cell count (to
exclude anemia and infection) and urinalysis (to exclude
infection). Serum electrolyte, glucose and calcium levels,
blood urea nitrogen, serum creatinine level and liver
function tests should also be done to investigate metabolic
disease (Quality Standards Subcommittee, 1994). Syphilis
serology, erythrocyte sedimentation rate, serum folate
level, human immunodeficiency virus (HIV) status, urine
check for heavy metals and toxicology screening may be
indicated in a minority of cases (Rabins, Lyketsos &
Steele, 1999).

Lumbar puncture is usually not necessary

except when the onset of dementia occurs before 55 years of
age or when a specific condition such as infection,
syphilis or vasculitis is suspected (Quality Standards
Subcommittee, 1994). The physical examination should also
include assessment of cognitive domains, including speech
(aphasia), motor memory (apraxia), sensory recognition
(agnosia) and complex behavior sequencing (executive
functioning) (Kramer & Duffy, 1996). This often requires
referral for neuropsychological assessment (Drane & Osato,
1997).
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Aphasia is a disorder that results from damage to
language centers of the brain.

It can also occur with

damage to the connections between centers of transcortical
aphasia.

Some individuals with aphasia have difficulty

with expressive language (what is said) while others have
problems with receptive language (what is understood).
Language can be affected not only in its oral form (talking
and comprehending) but also in its written form (reading
and writing).

Word finding problems (dysnomia/anomia) are

common in people with aphasia.

Asking the individual to

name body parts or objects in the room may informally
assess aphasia. Frequent use of vague terms such as "thing"
and "it" may also signify deterioration of language
function (Kertesz, 1994).
Apraxia is a motor disorder of action planning in
which volitional or voluntary movement is impaired without
muscle weakness.

Heilman, Watson and Rothi (2000) defined

apraxia as a disorder of skilled movement not caused by
weakness, akinesia, deafferentation, abnormal tone or
posture, movement disorders such as tremors or chorea, poor
comprehension, or uncooperativeness.

An example of a test

for apraxia is to ask the patient to pantomime the use of a
common object such as a hammer or a toothbrush (Taylor,
1994).
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Agnosia is defined as the loss of ability to perceive
or recognize sensory stimuli (i.e., objects, people,
sounds, shapes or smells).

One way to assess for agnosia

is by first asking the patient to close his or her eyes and
then placing an object, such as a key or a coin, in the
patient's hand and asking the patient to identify it
without looking at it. Ringing a bell or honking a horn can
evaluate auditory agnosia.

Asking the individual to

identify a common scent (i.e., vanilla or lemon) can test
olfactory agnosia.

Inability to recognize a common object

despite normal sensory thresholds signifies agnosia (Kramer
& Duffy, 1996).
Osborn (1998) defined executive functioning as the
ability to organize thought and work, to create plans and
successfully execute them, and to manage the administrative
functions of one’s life.

Asking the patient to perform a

series of simple tasks is a way to evaluate executive
functioning. For example, the individual can be asked to
sign a piece of paper, put the piece of paper in his or her
right hand, fold it in half and put it on the floor. This
task would be difficult for a person with impairment in the
ability to plan, initiate, sequence and monitor complex
behavior. Asking the person to perform serial subtraction
of 7s (backward from 100 to 65), to spell the word "world"
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backward and to produce verbal word lists, such as names of
animals or items in a grocery store, are other ways to test
executive functioning and abstract thinking.
Neuropsychological Tests
Neuropsychological tests are often administered to
assess difficulties in attention span, perception, memory,
problem solving, and social and language skills.

These

tests are often used to screen for cognitive impairment
that may be indicative of a dementing process.

An

individual’s responses on a neuropsychological battery may
also provide clues to the underlying cause of dementia. For
example, Jefferson et al. (2002) found that individuals
with Alzheimer’s disease showed differential impairment on
the Mini Mental State Examination (MMSE) indices measuring
orientation and memory when compared to individuals with
ischemic vascular dementia (IVD) and Parkinson’s disease
(PD).

The IVD and PD groups performed significantly worse

than the persons with AD on the MMSE indices assessing
working memory and motor/constructional functions.

The

authors therefore concluded that these indices could assist
clinicians in deriving important information regarding the
etiology of a patient’s dementing illness.
Common neuropsychological tests used for the
assessment of dementia include: Folstein’s Mini Mental
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State Examination (1975), the Neurobehavioral Cognitive
Status Examination (1989), and the Mattis Dementia Rating
Scale (1976, 1988).
The Mini Mental State Examination (MMSE; Folstein,
1976) is a brief, quantitative measure that has been widely
used for assessing cognitive mental status. This test can
be used to screen for cognitive impairment, to estimate the
severity of mental impairment at any given point in time,
to follow the course of cognitive changes in an adult over
time, and to document an individual’s response to
treatment. The MMSE has demonstrated validity and
reliability in psychiatric, geriatric, neurologic, and
other medical populations (Mitrushina & Saltz, 1991;
Tombaugh et al., 1996).

However, studies have shown that

it has limited specificity with respect to individual
clinical syndromes (e.g., dementia or delirium) (Kirby et
al., 2001; Tierney et al., 1997; Sabe, Jason, Juejati, &
Leiguarda, 1993).

The test assesses orientation,

attention, immediate and short-term recall, language, and
the ability to follow simple verbal and written commands.
Furthermore, it provides a total score that places the
individual on a scale of cognitive function.

The maximum

MMSE score is 30 points, individuals with a score of 23 may
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be experiencing dementia (Sabe, Jason, Juejati, &
Leiguarda, 1993).
The Neurobehavioral Cognitive Status Examination (CSE;
1989) is a standardized test instrument for assessing
cognition. It is designed to rapidly assess intellectual
functioning in five major areas: language, constructional
ability, memory, calculation skills, and
reasoning/judgment. Three general factors are also
examined: level of consciousness, attention, and
orientation. The test requires less than 5 minutes to
administer to individuals with “normal” functioning, and
10-20 minutes for those who are impaired. The NCSE can be
compared to the Mini-Mental State Exam (MMSE).

Studies

investigating the reliability of the NCSE demonstrate good
test-retest reliability, but poor inter-rater reliability
(Lamarre & Patten, 1994). Few independent validation
studies are available for this instrument.

Drane and Osato

(1997) found the NCSE can be used to successfully identify
cognitive dysfunction in all patients with a diagnosis of
dementia (high sensitivity) but there were major problems
with the specificity of the test.

The researchers found

the NCSE to generate an unacceptable level of false
positives among the healthy older adults (70%).
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Therefore,

this test should not be used alone as a screening
instrument for dementia.
The Dementia Rating Scale (DRS; Mattis, 1976, 1988) is
a well-known and widely used instrument for assessing
dementia.

It consists of five subscales that evaluate

attention, perseveration and initiation, construction,
memory, and conceptualization.

The DRS is composed of

simpler items than traditional cognitive tests, thus
decreasing its susceptibility to floor effects and
increasing its sensitivity to individuals with substantial
cognitive defects (Marson, Dymek, Duke, & Harrell, 1997).
It is brief and easy to administer, typically taking
between 20 to 40 minutes. Researchers have demonstrated
that that the scale has excellent test-retest and interconsistency reliability (Vitaliano et al., 1984) as well as
construct and criterion related validity (Vitaliano et al.,
1984; Vitaliano, Russo, & Breen, 1986).

The DRS total

score also appears to validly quantify cognitive impairment
for individuals with dementia (Moss & Alberts, 1988; Shay
et al., 1991).

The DRS also can be used to track changes

in cognitive status over time.
The Assessment of Dementia among Persons with MR
The standard clinical criteria for diagnosing dementia
may be inadequate for assessing individuals with
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developmental disabilities.

Often, individuals with MR do

not present the traditional clinical signs of dementia
(i.e., cognitive deterioration) or these signs may be
difficult to detect (Menolascino & Potter, 1989).

For

instance, individuals with developmental disabilities often
demonstrate cognitive deficits such as memory impairment,
receptive/expressive communication delays, and executive
functioning disturbances at an early age. The mere presence
of these cognitive deficits does not equate to a diagnosis
of dementia because these impairments may have been present
throughout the persons’ life (Haveman et al., 1994).
Therefore, in persons with mental retardation, a
diagnosis of dementia should be made based on a change in
status from their baseline functioning (Aylward, Burt &
Thorpe, 1997). For instance, the cognitive decline must
interfere with the individual’s previous level of social or
occupational functioning. Because evidence of decline in
previous abilities is necessary, a personal knowledge of
the individual is invaluable to the clinician to establish
a diagnosis. Unfortunately, because individuals with MR
often have poor to no communication skills and loss of
speech is a common behavioral symptom of dementia, use of
self-report methods is often impossible (Aylward, Burt &
Thorpe, 1997).

Impairments in verbal skills make it
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difficult for many individuals with developmental
disabilities to articulate abstract or global concepts such
as confusion and disorganized mental abilities.

According

to Haveman et al.’s (1994) study, approximately 12% of
residents in a large-scale residential facility in the
Netherlands could not express themselves verbally and
showed no signs of comprehension.

Another 27% were very

restricted in their communication skills.
Self report may be inappropriate for even those
individuals with intact expressive language skills because
researchers have demonstrated that often, as dementia
becomes more severe, patients become less aware of their
memory impairment (McDaniel et al., 1995).

Therefore, a

caregiver’s report may be more accurate than information
obtained from the individual.

Sevush (1999) found that

caregivers’ evaluation of the patients’ memory had better
associations with the patients’ dementia status and tested
cognitive performance than the patients’ own evaluation.
Therefore, an alternative to self-report is the use of
caregiver interviews and informant questionnaires (Zelinski
& Gilewski, 1988).

Standardized instruments that have been

found to be useful for eliciting information from
caregivers include the Dementia Questionnaire for Mentally
Retarded Persons (DMR; Evenhuis, Kengen, & Eurlings, 1990;
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Evenhuis, 1992, 1996), the Dementia Scale for Down’s
Syndrome (DSDS; Gedye, 1995), and the Early Signs of
Dementia Checklist (Visser & Kuilman, 1990).
These interviews should be completed with individuals
who are familiar with the person’s everyday behavior
(Gedye, 1995).

The informants should know the person well

and have a significant amount of contact with him/her.
Someone who was familiar with the person prior to the
dementing process is always preferable.

This method allows

the clinician to establish the symptoms’ mode of onset
(abrupt versus gradual), progression (stepwise versus
continuous decline, worsening versus fluctuating versus
improving), and duration.

This retrospective information

is also critical to determine whether there has been a
change in baseline functioning.

When the individual lives

in an institution or group home with multiple caregivers,
it is recommended that multiple informants be interviewed
(Gedye, 1998).
Information from individuals familiar with the patient
is beneficial but caregiver reports should not be the only
source of data.

Researchers have found that there are

often incongruencies between caregiver reports and
objective test measures, with some informants overreporting the severity of symptoms and others under-
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reporting impairment.

Prosch-Huy (2001) found significant

differences between informant reports and scores on the
Folstein Mini Mental State Exam (MMSE), with impairment
appearing more severe when measured by MMSE than caregiver
report. In contrast, DeBettignies, Mahurin, and Pirozzolo
(1993) found that caregivers of adults with Alzheimer’s
disease rated the patients as being more functionally
impaired than what was revealed by actual performance
testing.
Because informant reports may be unreliable and
inconsistent and retrospective reports may be flawed
(especially reports about memory or cognitive functioning),
direct assessment of the individual is critical to
supplement information supplied by caregivers.

The most

objective way to measure changes in cognitive and adaptive
functioning is the longitudinal administration of tests
that assess level of impairment (Aylward, Burt, Thorpe,
Lia, & Dalton, 1995).

In order to do this; the Working

Group for the Establishment of Criteria for the Diagnosis
of Dementia in Individuals with Intellectual Disabilities
recommended that all adults with mental retardation undergo
a comprehensive evaluation (i.e., intellectual assessment,
evaluation of adaptive functioning, assessment of
psychopathology, and mental status exam) at least once by
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the age of 25 years (Aylward et al., 1995).

This allows

the clinician to establish a record of baseline functioning
(Burt & Aylward, 1999).
Cognitive Assessment
Standardized, individually administered intelligence
tests are the most important instruments used to diagnose
mental retardation (Sattler, 1992).

These tests can also

be used to track changes in cognitive abilities by
comparing the individual’s performance over time.
Unfortunately, dementing processes are often difficult to
identify among persons with intellectual disabilities
because subsequent cognitive impairments can be
indiscernible (Shultz et al., 1998).

Current standardized

measures of intellectual functioning may be uninformative,
especially in people with very low IQ, as the score may
already be so low that no changes are observed with a
further dementing process (Janicki, Heller, Seltzer, &
Hogg, 1996).

Dalton, Seltzer, Adlin, and Wisniewski (1993)

attempted to detect cognitive deficits indicative of
dementia in persons with Down syndrome.

They found that

commonly used instruments for assessing cognitive
functioning are unreliable in persons with lower cognitive
abilities.

These measures are often insensitive at the

lower end of the cognitive spectrum often causing
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individuals with MR to score very poorly due to the so
called “floor effect” (Sattler, 1988).
Additionally, many of the mental status exams that are
used to evaluate dementia in the general population are not
appropriate for use with persons with mental retardation.
The mental status exams were designed for individuals whose
previous level of cognitive functioning was assumed to be
normal (Aylward et al., 1995).

Researchers have noted that

people who demonstrate “below average” performance on
intelligence tests often perform poorly on tests of mental
status.

These individuals are likely to be labeled

“cognitively declined” because of biases built into the
measures rather than due to true decline (Shultz, Aman &
Rojahn, 1998; Zelinski & Gilewski, 1988).

Several mental

status examinations have been developed or adapted for use
with persons with developmental disabilities.

These

include the Down’s Syndrome Mental Status Examination
(DSMSE) and the Test of Severe Impairment (TSI).

The DSMSE

(Haxby, 1989) consists of a battery of neuropsychological
tests assessing a broad range of skills, including recall
of personal information, orientation to season and day of
the week, memory, language, visual-spatial function and
praxis.

The TSI (Albert & Cohen, 1992) also covers a broad

range of cognitive functions, including motor performance,
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language comprehension, language production, immediate and
delayed memory, general knowledge and conceptualization.
These tests can be repeated periodically to compare results
over time.
Non-Cognitive Assessment
Because cognitive changes are often not readily
discernable, clinicians often rely on behavioral symptoms
to determine a diagnosis of dementia.

In fact, these “non-

cognitive” aspects of dementia are often the first signs
reported in individuals with MR (Cooper & Prasher, 1998;
Evenhuis, 1990; Janicki et al., 1992). Behavioral changes
such as irritability, increased wandering, sleep
difficulty, urinary incontinence, loss of interest and
anhedonia have been related to the development of dementia
in persons with MR (Janicki et al., 1995; Prasher,
Krishnan, & Clarke, 1994).

Other behavioral symptoms that

may be indicative of dementia include changes from
previously higher levels of adaptive functioning, loss of
speech, seizures in previously unaffected individuals,
disorientation, and increase in stereotyped behavior
(Aitken, Simpson & Burns, 1999; Bozzola, Gorelick, & Freels
et al., 1992; Cummings et al., 1994; Janicki et al., 1995).
The challenging behaviors displayed by older adults with
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dementia may be separated into two categories: behavioral
deficits and behavioral excesses (Burgio, 1996).
Behavioral deficits, wherein the non-occurrence of a
behavior constitutes a problem, are key defining
characteristics of mental retardation.

These deficits may

have been noted in functional and social domains since
childhood (Aylward et al., 1995).

However, individuals

with mental retardation may present with further decline as
they age (e.g., lose ability to perform daily living skills
that were previously mastered, become less verbal, and
limit social interaction).

Declines in social and adaptive

functioning beyond baseline levels are a cardinal
diagnostic feature of dementia (Shultz, Aman & Rojahn,
1998).
Although some decline in adaptive functioning is
expected as an effect of normal aging, decline in the
ability to perform activities of daily living is even more
pronounced among individuals with dementia.

For instance,

Zigman et al. (1994) found the level of adaptive
functioning significantly decreased in individuals with
Down’s syndrome aged 50 years and older.

Schupf, Lubin and

Silverman (1987) analyzed records of 2144 individuals with
Down’s syndrome and of 4172 controls diagnosed with mental
retardation of other etiology.
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They found that adaptive

competence declined with increasing age to a greater extent
for individuals with Down’s syndrome than for controls with
other intellectual disabilities.

The declines noted by

Zigman et al. (1994) and Schupf and associates (1987) is
presumably attributed to the presence of dementia among
aging persons with Down’s syndrome.

It is known that all

individuals with Down’s syndrome develop the characteristic
neuropathological brain lesions of Alzheimer’s disease
(i.e., neuritic plaques, granulo-vacuolar changes, cerebral
vascular amyloidosis, Hirano bodies and neurofibrillary
tangles) by the age of 40 years (Lai & Williams, 1989).
Individuals with Down’s syndrome are not the only
individuals who present with declines in adaptive behavior.
Draper et al. (2000) found that subjects with dementia had
greater functional impairments than controls.

For

instance, individuals with dementia participated in less
social activities.

Norbergh et al. (2001) investigated the

activity of demented patients at a psycho-geriatric unit.
The findings showed that persons with dementia who reside
in an institution often experience lives of solitude.
Armstrong-Esther and Brown (1996) found similar results
among patients in a geriatric ward where the individuals
spent 88.5% of their time alone.

Low social engagement,

decreased initiation and lack of interest are common
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behavioral symptoms associated with dementia.

Apathy,

which broadly defines these symptoms, occurs in up to 92%
of individuals diagnosed with dementia (Mega et al., 1996).
Researchers have also found that the presence of
dementia has dramatic impact on one's communication skills.
Draper and colleagues (2000) found that expressive
communication skills were significantly more impaired in
persons with dementia with only 40% being able to
communicate “well enough most times” as compared to 80% of
controls.

One’s ability to communicate effectively is very

important.

It influences an individual’s capacity to

perform daily living skills, their ability to get their
needs met, and has dramatic impact on a person’s social
interactions.

Researchers have demonstrated that nursing

home staff interact more with individuals who can
communicate.

For instance, Elkman et al. (1991) found that

caregivers seldom go to demented patients who have
communication problems just to talk to them, and that less
time is spent with those individuals during the various
care activities.
Although individuals with dementia often present with
loss of speech, vocally disruptive behavior, in addition to
physical aggression, is one of the most challenging
behaviors for nursing home staff to manage (Everitt et al.,
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1991; Whall et al., 1992).

Disruptive vocalizations

include loud requests for attention, chronic screaming,
self-talk, negative remarks, and use of obscenities
(Vaccaro, 1990).

Physically aggressive behaviors include

pushing, spitting, grabbing, kicking, hitting, and other
dangerous, assaultive behaviors (Cohen-Mansfield, 1989).
Rosen et al. (1994) reported that verbal and physical
aggression occurred in approximately 80% of nursing home
residents diagnosed with dementia. Physical aggression is
more common among moderately to severely demented
individuals and occurs most often during daily care
routines (Hoeffer et al., 1997).

These maladaptive

behaviors are often referred to as behavioral excesses
because the occurrence of these behaviors constitutes the
problem (Cohen-Mansfield et al., 1989).
The main factors that seem to contribute to vocally
disruptive and physically aggressive behavior are severe
impairment in the performance of daily living skills, pain,
and communication difficulties (Cohen-Mansfield & Werner,
1997).

If we interpret this from a functional standpoint,

all behaviors serve a communicative purpose. Individuals
with dementia who are no longer able to express themselves
with language may use disruptive behavior to reflect an
underlying need or discomfort, or a response to
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environmental or physical stimuli.

Researchers have

demonstrated that staff members’ responses to these
behaviors often inadvertently reward the individual,
thereby increasing or maintaining the current rate of
aggressive and/or disruptive behavior (Vaccaro, 1990).

For

instance, staff members may provide the individual with
either positive or negative attention (i.e., comforting the
person or attempting to stop the behavior through loud
verbal reprimands). Parenthetically, even negative
attention is rewarding to someone whose schedule of
reinforcement is really lean.
Other symptom clusters that are common among persons
diagnosed with dementia are “psychosis” (hallucinations,
delusions, paranoia), “depression” (sad appearance, crying,
guilt, anxiety), and “motor hyperactivity or psychomotor
agitation” (pacing, aimless walking, handling objects
inappropriately) (Aitkin, Simpson & Burns, 1999).

These

“non-cognitive” symptoms are commonly associated with the
degenerative changes of dementia and they are often the
first or only identifiable signs of dementia in persons
with developmental disabilities (Moss & Patel, 1995). These
behavioral challenges often increase in severity and
frequency as the dementia progresses (Cooper et al., 1990;
Jacomb et al., 1994).
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Rationale and Purpose
Short of autopsy, there are no conclusive biological
markers for the most common forms of dementia (Rogan &
Lippa, 2002).

Therefore, diagnosis is often based on

objective longitudinal evidence of deterioration of
cognitive abilities and evidence of deterioration in
adaptive behavior and/or social skills especially in
persons with MR (Aylward et al., 1995).

Although these

longitudinal changes are essential to diagnose dementia
(APA, 1994), groups of investigators have, to some extent,
developed their own classification methods (Aylward, Burt &
Thorpe, 1997; Barcikowska, Silverman & Zigman, 1989; Burt &
Aylward, 1999; Janicki, Heller & Hogg, 1996; Prasher,
Krishnan & Clarke, 1994; Shultz, Aman, & Rojahn, 1998;
Silverman et al, 1998; Visser & Kuilman, 1990; Visser et
al., 1997).

Although these approaches share some

commonalities (e.g., investigating decline in functioning,
comparison between identified “dementia” and “non-dementia”
groups) they differ in their emphasis on different types of
data (e.g., use of various adaptive behavior measures,
mental status examinations, cognitive assessments, scales
of psychopathology, and caregiver reports) and analysis
(e.g., cross-sectional designs, longitudinal studies).
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Burt and Aylward (2000) considered a working battery
of tests for the diagnosis of dementia among persons with
intellectual disabilities.

The battery is divided into two

parts: administration of informant-report scales and direct
assessment of the individual with MR (Aylward et al.,
1997).

Administration of six informant report scales is

recommended.

These include the Dementia Questionnaire for

Mentally Retarded Persons, the Dementia Scale for Down
Syndrome, the Reiss Screen for Maladaptive Behavior, the
Scales of Independent Behavior – Revised, the AAMR Adaptive
Behavior Scale – Residential and Community (2nd Ed.), and
the Stress Index (Burt & Aylward, 2000).

The

administration time for each of these scales varies (i.e.,
according to their respective manuals, the AAMR Adaptive
Behavior Scale takes approximately 30 minutes to administer
(Nihira, Leland & Lambert, 1993) and the Scales of
Independent Behavior – R (Bruinink, Woodcock, Weatherman &
Hill, 1996) takes approximately 60 minutes).
Administration is manageable when one or two of these
scales are used; however, administration of all six scales
is quite time-consuming.

Burt and Aylward (2000) also

selected 10 instruments to be administered directly to the
individual with MR (the Test for Severe Impairment,
Stanford Binet Sentences, the Fuld (modified),
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Autobiographical Memory, Orientation, the Boston Naming
Test, the McCarthy Verbal Fluency, Simple Commands, the
Purdue Pegboard (modified), and the Developmental Test of
Visual Motor Integration).

The researchers noted that all

of the tests have the capacity to assess individuals with
MR ranging from mild to profound levels but this statement
can be disputed.

For example, several tests recommended

are inappropriate for individuals with limited to no verbal
skills.

According to “administration notes” provided by

Burt and Aylward (2000), four of the ten instruments
require “speech which is clear enough to score.”

Also,

persons with receptive language deficits may have
difficulty comprehending task instructions.

Persons with

fine motor difficulties are likely to perform poorly on
three instruments that require manipulation of small
objects and the ability to maneuver a pencil across paper.
In addition, it is likely that individuals with short
attention spans would have difficulty completing the
battery in a single sitting therefore multiple sessions
would be required.

Fatigue and frustration would also make

completion of the battery challenging.

Therefore, it is

believed that though these instruments may be effective in
assessing dementia among individuals with mild and moderate
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MR, use with persons with severe and profound MR is
dubious.
Visser et al. (1997) also proposed a method to detect
dementia in individuals with Down’s syndrome.

Visser et

al.’s (1997) clinical diagnosis of dementia is based on
specific clinical symptoms, changes in social skills, and
changes in the background alpha rhythm measured by the EEG.
The researchers categorized 307 participants into five
groups based on the participant’s performance on the Early
Signs of Dementia Checklist (ESDC, Visser & Kuilman, 1990),
scores on the Social Skills Inventory for the Mentally
Retarded (Sociale Redzaambeids-shaalvoor Zwakzinnigan;
Kraijer & Kema, 1981) and EEG recordings as follows: Group
1 = no deterioration, Group 2 = onset of deterioration,
Group 3 = distinct behavioral change, Group 4 = advanced
dementia and Group 5 = time of complete dependency. Visser
et al. (1997) established the validity of this method by
comparing their clinical findings with postmortem
neuropathological findings. Permission was obtained to
perform an autopsy on 16 patients who died during the
course of the study (13 identified with clinical dementia,
3 did not meet Visser et al. (1997) criteria for dementia).
A very strong correlation was found.

The 13 patients who

were clinically diagnosed as having dementia using their
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method also presented with brain changes consistent with
severe forms of Alzheimer’s disease.

For instance, senile

plaques, neurofibrillary degeneration at the frontal and
temporal cortices, severely disrupted interneuronal
networks, and neurofibrillary degeneration in the
parahippocampal gyrus and the hippocampus were found.
Neuroanatomic evidence of Alzheimer disease was not in the
autopsy findings in the three other deceased participants
who did not meet clinical criteria of dementia.
One particular advantage of the Visser et al. (1997)
model is its suitability for use on individuals who have a
low level of intellectual functioning.

The collection of

information about aspects of cognitive functioning is not
time consuming and the measures were found to be patientfriendly because they do not involve assessment interaction
with the individuals.

Another advantage is the converging

vectors looking at resident behavior via serial evaluations
of participants, caregiver reports with the Early Signs of
Dementia Checklist, and the physiological exam findings
with the EEG.

When all three of these vectors converge,

good confidence can be placed in the clinical diagnosis of
dementia.
The purpose of this present study was to apply Visser
et al.’s (1997) model to determine whether it could detect
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dementia among persons diagnosed with severe or profound
mental retardation using a social skills measure in common
use in facilities in the U.S.

The primary reason for

focusing on this group of individuals is because persons
with severe and profound mental retardation demonstrate the
greatest communication deficits and lowest baseline
abilities thereby making the identification of dementia
based on standard methods such as cognitive assessments and
mental status exams quite difficult.

This study is more

than just a replication of Visser et al.’s research as
individuals with and without Down’s syndrome were sampled.
Much of the research on dementia among persons with MR has
been conducted with individuals with Down’s syndrome.

It

is felt that additional studies need to be conducted
comparing the prevalence and course of dementia among
persons with and without Down’s syndrome. In addition, the
Matson Evaluation of Social Skills in Individuals with
Severe Retardation (MESSIER; Matson, 1995) was used rather
than the Social Skills Inventory for the Mentally Retarded.
The Social Skills Inventory for the Mentally Retarded does
not have an English-version.

Several steps would need to

be completed before use of this measure would be
appropriate in the United States (e.g., translation,
cultural adaptation, validation for use in the U.S.,
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assessment of the psychometric equivalencies across English
and Dutch versions).

This process is very time consuming

and can be avoided if it can be validly replaced with
another well established measure that assesses social
skills in individuals with MR. The MESSIER was chosen
because it has demonstrated itself to be a reliable and
valid measure of social skills in persons with severe and
profound MR in the United States.
Visser et al. (1997) were able to gather neuroanatomic
evidence of Alzheimer’s disease on 13 participants who died
during the course of their study.

However, postmortem

neurological assessments were excluded from this present
investigation.

Therefore, because of the problem of making

an ironclad determination of dementia without evidence of
deterioration of brain tissue, a differential prevalence
design was used.

Differential prevalence designs are often

used in research to distinguish malingerers from nonmalingerers.

This group is another for whom diagnostic

confirmations are extraordinarily difficult to obtain.
Research on malingering often involves groups of people
claiming brain dysfunction who are in litigation with
groups of people claiming brain dysfunction who are not in
litigation, under the assumption those who are in
litigation may be malingering and those who are not in
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litigation are not (Greve et al., 2003).

Differential

prevalence designs are not a guarantee of true assignment.
For instance, some individuals grouped as “non-malingering”
may indeed be malingering and some grouped as malingerers
may be truthful.

The problem is that there is no “gold

standard” and assignment to “known groups” is only possible
if a malingerer is “caught”.

Researchers also believe that

those caught do not represent the true population of
malingerers.

Rather, they likely represent unsophisticated

malingerers who are easy to detect (Millis, Ross & Ricker,
1998).

Using a differential prevalence design for this

particular study enables us to compare three groups of
individuals who vary in risk for dementia.
Validating Visser et al.’s (1997) method on an
American sample is important in light of the dramatic
increase of the elderly population of adults with MR in the
United States (persons susceptible to dementing processes)
and the increased interest in the accurate detection of
dementia in persons with developmental disabilities.

Early

detection is important because there are numerous reports
in which the course of dementia can be arrested and in some
cases even reversed. Thase (1982) reported a case of
reversible dementia secondary to hypothyroidism.

A

complete psychological/physical assessment indicated
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dementia secondary to low thyroid functioning.

The patient

fully recovered to premorbid functioning when the
appropriate treatment was administered.

Gedye (1998)

described four cases of neuroleptic induced dementia among
individuals with intellectual disabilities.

These

individuals returned to their previous functional states
when the offending medications were discontinued.
Early identification of dementia has important
clinical implications because it can guide treatment
planning and clinical care.

Clinicians can use this data

to identify decline in previous capabilities and then
intervene in order to retrain these skills or prevent
further loss.

In addition, this data can be used to

identify an individual’s spared abilities and treatment
strategies can be designed to further tap into and take
advantage of these facilities.

It is believed that good

clinical data on the early signs and course of dementia
will eventually result in a better outcome for aging
persons with mental retardation.
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Hypothesis
Hypothesis #1 - It was hypothesized that individuals
who belonged to the “high risk” group would demonstrate
fewer positive social skills (as evinced by low MESSIER
Positive scores and high MESSIER Negative scores) and more
characteristic symptoms of dementia (as noted by ESDC item
endorsements) than persons in the “medium risk” and “low
risk” groups.

Individuals identified as “medium risk”

would perform worse on the MESSIER Positive and Negative
scales and ESDC than persons in the “low risk” group.
Hypothesis #2 – It was hypothesized that individuals
with Down’s syndrome would perform worse than persons
without Down’s syndrome across the “high” and “medium risk”
levels.

However, an interaction was predicted, in that

Hypothesis #2 would not hold in the “low risk” group.

That

is, young persons with and without Down’s syndrome would
demonstrate little symptoms characteristic of dementia.
Hypothesis #3 – It was hypothesized that the rate of
decline in social abilities would be greatest for
participants with Down’s syndrome who had been identified
as “high risk”.
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Method
Participants
Participants were 90 individuals residing at a large
developmental center in Louisiana.

The sample size was

based on results from an a priori power analysis with alpha
= .05, power = .80 and the effect size = .30.

This effect

size is based on an average of several effect sizes
reported in dementia research (Burt et al., 1995; Prasher &
Chung, 1996; Zigman et al., 2004).

All participants were

classified, prior to the study, as having severe or
profound mental retardation based on DSM-IV criteria (APA,
1994).

Fifty-nine of the ninety participants (65.5%) were

diagnosed with profound mental retardation.
Using a differential prevalence design, participants
were equivalently selected for assignment to one of three
groups based on their perceived “risk for dementia”.

These

groups were selected with the intention that assigning
participants to three extreme groups would increase power
and likely effect.

The high-risk group comprised of 30

individuals who had been referred for psychological
assessment in order to screen/rule out for dementia.

These

individuals had been referred by direct care staff members
or by psychology staff because of observed behavioral,
cognitive, personality, or social skill changes.
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No age

limitations were imposed on this group therefore
individuals in the high-risk group ranged from 41 years to
92 years, with a mean age of 57.1 years.

The medium risk

group was made up of 30 “old age” individuals who had not
been referred for evaluation.

“Old age” was defined as

persons aged 55 years or older.

Age 55 was selected

because researchers have generally defined “old age” in
persons with MR as those individuals 55 years and older
(Seltzer, 1992).

This age cut off seems arbitrary but the

criteria are based on several factors including attempts to
include some subgroups that seem to age prematurely (i.e.,
individuals with Down’s Syndrome and individuals with
Cerebral Palsy), observations of changes of functions among
individuals with MR, and expectations for change in normal
age related activities (Seltzer, 1992; Seltzer & Krauss,
1987).

These individuals represented the aging population

of persons with MR who had not been referred by caretakers
due to observed decline/change.

The mean age of the medium

risk group was 59.9 years, with individuals ranging from 55
to 68 years.

The low risk group was comprised of 30

individuals aged 40 years or younger (mean age = 36.1) who
had not been referred for a neuropsychological assessment.
One half of the participants for each of the three
risk groups were comprised of individuals who have Down’s
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syndrome (DS) (n = 45).

Every Down’s syndrome subject was

identified by their characteristic facial features and
medical records establishing Down’s syndrome.
Table 1
Group Assignment

Down Syndrome
Non-DS

High Risk
n=15
n=15

Medium Risk
n=15
n=15

Low Risk
n=15
n=15

An attempt was made to match the groups on four
factors: gender, level of mental retardation (severe or
profound), other psychiatric diagnoses, and psychotropic
medication.

It is important to match the individuals on

“other psychiatric diagnoses” in order to confidently state
that significant differences in scores on measures of
social skills and current cognitive functioning are a
factor of a dementing process rather than the person’s comorbid Axis I diagnosis.

Participants were matched on

medication to minimize the possibility that loss of skills
is due to medication side effects (i.e., lethargy, physical
discomfort, etc.).
Interviewers and Informants
All interviewers were master’s level psychologists
with training specific to the area of mental retardation.
Interviewers were trained in the administration of the
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assessment instruments by a licensed supervising
psychologist or a trained doctoral student in clinical
psychology, and had been employed at the developmental
center for at least one month prior to conducting
interviews.

Informants (the individual providing answers

to the assessment questions) were direct support staff who
had worked with the participants for a minimum of 12
months.

All informants held the title of either home

manager (charge staff) or group leader.
Table 2
Demographic Variables
Age
High

Down’s
Syndrome

50.7 yrs

No
Down’s

63.5 yrs

Down’s
Syndrome

58.2 yrs

Risk

No
Down’s

61.6 yrs

Low

Down’s
Syndrome

36.5 yrs

No
Down’s

35.7 yrs

Participants
with Axis I
diagnosis

Participants
on
psychotropic
meds

Profound = 11

5

3

6

6

5

2

5

4

5

3

7

4

Severe = 4

Risk

Medium

MR Level

Profound = 11
Severe = 4
Profound = 10
Severe = 5
Profound = 9
Severe = 6
Profound = 9
Severe = 6

Risk

Profound = 9
Severe = 6

Predictive Measures
Matson Evaluation of Social Skills in Individuals with
Severe Retardation. The Matson Evaluation of Social Skills
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for Individuals with Severe Retardation (MESSIER; Matson,
1995) was used as a measure of social skills.

The MESSIER

was specifically designed to assess social skills in
persons with severe and profound mental retardation.

It

consists of 85 items generated from a review of existing
social skills measures for children and adults, items from
the social and communication domains of adaptive behavior
scales, and items nominated by experts.

The items are

grouped into six clinically derived subscales: 1) positive
verbal, 2) positive non-verbal, 3) positive general, 4)
negative verbal, 5) negative non-verbal, and 6) negative
general.

Each item is rated on frequency using a four-

point Likert: never (0), rarely (1), sometimes (2), and
often (3).

The MESSIER is administered by a trained

examiner in a semi-structured interview format.

The

respondent should be a caregiver who has worked with the
individual for at least six months.
The psychometric properties of the MESSIER have been
studied.
was high.

Internal consistence and test-retest reliability
Good correlations were also found between raters

for the total MESSIER score and for all positive and
negative MESSIER items (Matson, LeBlanc, Weinheimer &
Cherry, 1999).

The convergent validity of the MESSIER was

evaluated by comparing it to the Socialization domain of
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the VABS and sociometric ratings.

Significant positive

correlations were found between corresponding MESSIER
subscales and VABS subdomains on social behaviors. Although
the MESSIER and VABS (Socialization domain) seem to measure
similar constructs, the MESSIER was used in this study
because it has several advantages over the VABS in
measuring social skills in persons with severe and profound
mental retardation.

First, the MESSIER has a large number

of social skills specific questions than the VABS.

Second,

the MESSIER can be used to illustrate an individual’s
social skills and deficits, as well as maladaptive behavior
excesses, whereas the VABS is limited to providing
information about social abilities only.
Early Signs of Dementia Checklist (ESDC; Visser &
Kuilman, 1990).

The ESDC is a scale designed to assess for

clinical signs of mental deterioration.

The instrument

consists of 37 questions divided over 9 categories
(General, Personality Changes, Decrease in Performance,
Deterioration of Language Skills, Deterioration of Gait,
Disorientation, Incontinence, Epilepsy, and Loss of SchoolAcquired Skills).

These categories were selected to

inquire about symptoms that have been found to occur with
deterioration associated with dementia (Ballard et al.,
2001).

There are, however, some troublesome items that may
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cause clinicians and researchers to over-predict dementia.
For instance, items are endorsed if an individual is
currently incontinent.

These endorsements may give the

impression that deterioration has occurred (i.e., it may
appear that an individuals who was able to toilet
independently is now having toileting accidents).

However,

it does not take into account that some persons with
limited self-help skills may have never acquired selftoileting skills and may have always relied on protective
undergarments and caregiver assistance.

Therefore, items

on the Incontinence section should be interpreted with
caution.

It is suggested that items should only be

endorsed if there is loss of continence (e.g., a change).
The ESDC is completed via interview.

The interviewer

should be a trained examiner familiar with the measure.
The respondent should be a caregiver who is familiar with
the individual and has worked directly with them for at
least 6 months.

Each item is scored on a binomial scale

(Yes- 1, No – 0).
The ESDC has demonstrated good psychometric properties
(internal consistency of 0.82 and an interrater reliability
of about 0.80).

It has also shown to be effective to

reliably detect Alzheimer-type dementia at an early stage
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when combined with a social skills inventory and EEG
(Visser et al., 1997).
Procedure
Retrospective data were utilized to ascertain decline
in social skills.

This method was accomplished by

conducting a chart review of the previous three annual
psychological evaluations for each participant and noting
the raw scores on the MESSIER Positive and MESSIER Negative
scales.

Data systems had been set up at the developmental

center several years ago with the intention of using the
data for research.
There was an approximate one-year interval between
administrations of the MESSIER (mean period between
administrations of the scale = 10.9 months).

This period

was selected because, in most instances, a one-year followup interval is adequate for monitoring changes in cognitive
performance (APA Presidential Task Force, 1998).

Visser et

al. (1997) noted that all their patients were in a
prodromal phase that lasted on average 1.3 years in which
the individuals showed aspecific clinical symptoms that
heralded the later progressive deterioration.

The duration

of the deterioration was considered to be the time between
the onset of distinctive dementia and complete dependency.
The mean duration of deterioration was 2.6 years.
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Current testing was completed to collect information
about the individual’s current functioning via interview
with direct care staff using the Early Signs of Dementia
Checklist (ESDC).

This measure was administered within 3

months of the most recent MESSIER screening in order to
limit the possibility of further changes in social skills
between test administrations (mean period between
administration of MESSIER and ESDC was 2.1 months).

The

ESDC was used to get a picture of the clinical signs of the
individual’s deterioration.

For this study, the items on

the “Incontinence” section were modified to more accurately
assess for observed changes in toileting skills.

This

modification was done to control for persons who may have
never acquired independent toileting.

The ESDC inquires

whether the resident shows urinary incontinence during the
day/night either occasionally or continuously and whether
the resident shows fecal incontinence.

An individual who

was never toilet trained may acquire points on the ESDC
despite these symptoms being present since baseline and
thus, not indicative of a deteriorating process.
Therefore, when administering this section, the interviewer
was first asked whether the resident was or ever had been
able to independently toilet.

If the reply was “no”, the

section was skipped.
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Results
Diagnostic Criteria
Following the example of Visser et al. (1997),
participants were categorized into one of 5 groups using a
cross tabulation procedure.

The purpose of this was to

show in tabular format the relationship between the 5
categorical values. Those individuals who did not show
evidence of decline based on a score of 4 or less on the
ESDC were labeled “non-deterioration” (N = 48).

A second

category “onset of deterioration” was used to describe
participants who had a score of 5 or higher on the ESDC but
who did not show 25% deterioration in their social skills
functioning (N = 27).

“Distinct behavioral change” was

used to describe individuals who showed 25% deterioration
in their positive social skills and a score of 10 or higher
on the ESDC (N = 12).

“Advanced dementia” was used to

categorize persons who showed 50% reduction in positive
social skills and at least 10 ESDC symptoms (N = 3).
Although some participants had minimal scores on the social
skills measure (reflecting the near absence of positive
social skills), none of the participants needed nursing
care for all domains of daily functioning.

Therefore

Visser et al.’s (1997) fifth category “complete dependency”
was omitted from our analyses.
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Next, participants in each of the four Visser et al.
categories were sorted further based on their “risk of
dementia” status.

Of the 48 participants categorized as

“no deterioration”, 10 belonged to the high risk group, 15
belonged to the medium risk group, and 23 belonged to the
low risk group.

Of the 27 participants labeled as “onset

of deterioration”, 11 were high risk, 10 were medium risk,
and 6 were low risk.

Six high risk, 5 medium risk and 1

low risk participant met criteria for “distinct behavior
change”.

All 3 participants identified as “advanced

dementia” belonged to the high risk group.
Table 3
Classification into 5 “Dementia Categories”
NonDeterioration

Onset of
Deterioration

Distinct
Change

Advanced
Dementia

High Risk

10

11

6

3

Medium Risk

15

10

5

0

Low Risk

23

6

1

0

These data demonstrate that, as compared to the medium
and low risk groups, individuals classified as high risk
had the least number of participants meeting Visser et al.
(1997) criteria for “no deterioration” but the greatest
prevalence of individuals meeting criteria for “advanced
dementia”.

Conversely, the low risk group had the greatest
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number of participants in the “no deterioration” category
and the least in the “distinct change” category.

Legend
ND = No Deterioration
OD = Onset of Deterioration
DC = Distinct Change
AD = Advanced Dementia

HIGH RISK GROUP
25
20
15
10
5
0

ND

OD

DC

AD

MEDIUM RISK GROUP
25
20
15
10
5
0

ND

OD

DC

AD

LOW RISK GROUP
25
20
15
10
5
0

ND

OD

DC

AD

Figure 1
Distribution of Dementia Category Frequencies
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Though the cross tabulation graphs look different for
the three risk referral groups, a hypothesis test was
performed on the contingency table to determine whether or
not dementia classification was distributed similarly
across the different “risk of dementia” groups.

The

observed frequencies were used to compute the expected
frequencies for the four Visser et al. (1997) categories.
It was determined that the expected count of individuals in
each of the Visser et al. categories for the high, medium
and low risk groups was as follows: “no deterioration” =
16, “onset of deterioration” = 9, “distinct change” = 4,
and “advanced dementia” = 1.

A chi square test compared

the expected and the observed frequencies in each cell.
Chi square is most frequently used to test the statistical
significance of results reported in a contingency table
(Brymer & Cramer, 2001)).

The computed chi square

statistic (χ) of .012 was less than .05 indicating that
assignment to the Visser et al. categories was not
distributed similarly across the different levels of risk.
The frequency of individuals meeting Visser et al. criteria
for dementia classification was related to their perceived
risk (e.g., individuals identified as high risk are more
likely to meet Visser et al. criteria for dementia than
individuals identified as low risk).
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Cross Sectional Analyses
A cross sectional analysis (multivariate analysis of
variance) was used to examine, at one point in time,
differences in ESDC total scores, MESSIER Positive total
scores, and MESSIER Negative total scores between persons
with and without Down’s Syndrome (independent variable #1 –
“syndrome”) and persons assigned to the three perceived
risk groups (independent variable #2 – “risk of dementia”).
This analysis yielded significant main effects for
“syndrome” (F(1,88)=4.566, p=.005)and for “risk of
dementia” (F(2,87)=5.844, p=.000).

An interaction effect

(syndrome * risk of dementia) was not identified
(F(5,84)=1.020, p=.414).

Please refer to Table 4 for means

and standard deviations.
Tests of between subjects effects indicated that
participants with Down’s Syndrome (M=14.22) had
significantly lower scores on the MESSIER Negative scale
(F(1,88)=13.491, p=.000) than participants without Down’s
Syndrome (M=25.27).

Significant differences were not noted

between the two syndrome groups on either the MESSIER
Positive (F(1,88)=.084, p=.772) or ESDC Total scores
(F(1,88)=1.491, p=.225).
Significant differences on MESSIER Negative
(F(2,87)=3.162, p=.047) and ESDC Total scores
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(F(2,87)=18.759, p=.000) were noted among individuals
assigned to the three “risk of dementia” groups.

A post

hoc test indicated significant differences (p=.048) between
the high and low risk groups on the MESSIER Negative scale
(M=24.567 and M =15.333, respectively).
Analysis revealed that the high risk group (M=8.467)
was also significantly different from both the medium risk
(M=4.033, p=.001) and low risk group (M=1.600, p=.000) on
the ESDC Total score.

However, significant differences

were not noted between the medium and low risk groups on
any of the three assessment scales (MESSIER Positive
p=.456, MESSIER Negative p=.557, ESDC p=.107). This
indicates that, despite a mean age difference of 23.8
years, scale scores were statistically similar among
individuals who were not referred for neuropsychological
assessment.
A separate analysis was completed on the total study
sample (N=90) in order to investigate possible age effects.
Participants were divided into 5 groups according to their
chronological ages.

Group 1 was comprised of individuals

between the ages of 30 and 39 years (N=28, Note: one
subject was less than 30 years but they were included in
group 1). Group 2 was made up of 12 individuals who were
between 40 and 49 years.

There were 26 participants
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between the ages of 50 and 59 years (group 3) and 19
participants between the ages of 60 and 69 years (group 4).
The fifth group contained all individuals who were 70 years
and older (n=5).

A multivariate analysis of variance was

conducted to determine whether there were significant
differences across age groups in terms of ESDC, MESSIER
Positive, and MESSIER Negative total scores.

Results

showed that age had a significant effect on the ESDC scores
(F(4,85)=4.651, p=.002).

Multiple comparisons were

completed in order to determine among which age groups
these differences were found.

Results showed that the 30-

39 year old group differed significantly from the 50-59
year old group (p=.046) and from the 60-69 year old group
(p=.031).

Age did not have a significant effect on either

the MESSIER Positive (F(4,85)=.248, p=.910) or MESSIER
Negative (F(4,85)=1.961, p=.108) scores.
Another series of multiple analyses of variance were
run to investigate the effects of our participants’
demographic characteristics on the scale scores.

Two

separate analyses were conducted to determine whether there
were significant differences across gender groups and
levels of mental retardation.

A significant difference

between males and females was not found on any of the three
dependent measures (ESDC – F(1,88)=.457, p=.501; MESSIER
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Positive – F(1,88)=.004, p=.952; MESSIER Negative –
F(1,88)=.466, p=.496).

However, a significant difference

between levels of MR was obtained when examining MESSIER
Positive scores (F(1,88)=13.16, p=.000).

Individuals with

severe MR had significantly higher MESSIER Positive scores
(M=102.48, SD=35.27) than participants diagnosed with
profound MR (M=76.02, SD=31.59).

A significant difference

between participants with severe and profound MR was not
found on either MESSIER Negative (F(1,88)=.052, p=.821) or
ESDC total scores (F(1,88)=.009, p=.923).
Table 4
Means and Standard Deviations for ESDC Total and MESSIER
Positive and Negative Scores
MESSIER
Referral Syndrome Positive
Status
Mean
S.D.
High

Medium

D.S.

MESSIER
Negative
Mean
S.D.

ESDC Total
Mean

S.D.

80.267

35.526 17.267 14.655 8.133 7.763

Non-D.S. 77.067

30.056 31.867 21.112 8.800 5.414

D.S.

37.107 14.000 8.036

87.267

2.533 2.642

Non-D.S. 100.800 29.898 24.667 13.500 5.533 3.159
Low

D.S.

91.067

40.013 11.400 11.544 1.733 2.219

Non-D.S. 74.333

35.407 19.267 13.419 1.467 2.200
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Cross Sectional Analysis of Clinical Symptoms
The clinical signs of dementia (as measured by the
ESDC) were investigated more closely with frequency counts
and a multiple analysis of variance. Results showed that
49% of our participants had at least one item endorsed on
the “Decreased Performance” scale of the ESDC.
Personality changes were endorsed for 44.4% of
participants, indicating recent changes in mood and an
exaggeration of personality traits.

Approximately one-

fourth (27.7%)of our participants presented with aspecific
clinical symptoms such as a decrease in interest, speed and
motivation.

Twenty seven percent of participants were

noted to experience some deterioration in gait and 27.8%
were beginning to occasionally show urinary incontinence.
To a lesser degree, participants showed signs of spatial
and temporal disorientation (13.3%) as well as
deterioration in language skills (15.6%).

Only 6 of the 90

participants demonstrated a loss of school-acquired skills,
specifically deterioration in the ability to read and
write, and only one participant developed epilepsy during
the course of the study.
A multivariate analysis of variance (MANOVA) was
conducted in order to establish whether an individual’s
“syndrome” or “risk of dementia” status influenced the
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items endorsed on the ESDC.

The results indicated that a

significant difference on the Personality Changes scale
existed among participants with DS (M = .8889) and persons
without DS (M = 1.4889) (F(1,88)= 6.231, p = .015).
Significant differences between “syndrome” groups were not
noted on any other ESDC scales.
A significant main effect for “risk of dementia”
(F(2,87)=3.382, p=.000) was also noted.

Tests of between-

subjects effects indicated that significant values were
obtained for all ESDC scales, with the exception of the
Epilepsy scale (F(2,87)=1.000, p=.372).

Multiple

comparisons were made (Sheffe post-hoc test) to identify
the specific differences within the groups.

Significant

differences were noted between the high and low risk groups
on the following scales: General (p=.003), Personality
Changes (p=.000), Decreased Performance (p=.000),
Deterioration of Language Skills (p=.000), Deterioration of
Gait (p=.002), Disorientation (p=.024), Incontinence
(p=.025) and Loss of School Acquired Skills (p=.030).
Significant differences between the high and medium risk
groups were noted on the Decreased Performance (p=.001),
Deterioration of Language Skills (p=.000) and Deterioration
of Gait (p=.006) scales.

A significant difference was
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noted between the medium and low risk group on the
Personality Changes scale (p=.001).
Longitudinal Analyses
Because reliable diagnosis of dementia requires
systematic documentation of age related performance
declines within affected people (APA, 1994), a series of
repeated measures analyses of variance were used to test
for significant changes in social abilities over time.

The

effects of referral status upon MESSIER Positive and
MESSIER Negative scores were investigated with two separate
two-way ANOVAs comparing the three “risk of dementia”
groups over the three test administrations.

Main effects

for “time” were noted for the MESSIER Positive
(F(2,87)=4.217, p=.016) and MESSIER Negative scores
(F(2,87)= 3.200, p= .043).However, a significant main
effect for “risk of dementia” was not noted for either the
MESSIER Positive (F(2,87)=1.093, p=.340) or MESSIER
Negative scores (F(2,87)= .393, p= .676).

Significant

interaction effects (Time * Risk of Dementia) were not
noted for MESSIER Positive (F(5,84)=2.003, p=.096) or
MESSIER Negative scores (F(5,84)= 2.001, p= .096).
The effects of syndrome group upon MESSIER Positive
and MESSIER Negative scores were also investigated.

Main

effects for “time” were noted for the MESSIER Positive
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(F(1,88)=4.078, p=.019) and MESSIER Negative scores
(F(1,88)= 3.105, p= .047).

A significant main effect for

“syndrome” was noted for MESSIER Negative scores (F(1,88)=
237.147, p= .000) but not for MESSIER Positive scores
(F(1,88)=1.093, p=.340). Significant interaction effects
(Time * Syndrome) were not noted for MESSIER Positive
(F(4,85)=2.003, p=.096) or MESSIER Negative scores
(F(4,85)= .288, p= .750).
Table 5
Longitudinal Analysis of MESSIER Positive Scores

High
Risk
Medium
Risk
Low
Risk

DS
Non-DS
DS
Non-DS
DS
Non-DS

Administration 1

Administration 2

Administration 3

M=92.86, SD=29.09

M=87.73, SD=27.18

M=80.27, SD=35.53

M=91.13, SD=29.65

M=88.60, SD=35.31

M=77.07, SD=30.06

M=89.20, SD=39.13

M=88.27, SD=35.28

M=87.27, SD=37.11

M=104.60, SD=35.63

M=98.40, SD=32.90

M=100.80, SD=29.90

M=94.33, SD=40.25

M=89.13, SD=36.39

M=91.07, SD=40.01

M=74.87, SD=31.93

M=72.60, SD=33.72

M=74.33, SD=35.09

Table 6
Longitudinal Analysis of MESSIER Negative Scores

High
Risk
Medium
Risk
Low
Risk

DS
Non-DS
DS
Non-DS
DS
Non-DS

Administration 1

Administration 2

Administration 3

M=10.93, SD=10.74

M=15.27, SD=16.30

M=17.27, SD=14.66

M=20.67, SD=14.07

M=22.80, SD=18.70

M=31.87, SD=21.11

M=11.93, SD=5.84

M=11.67, SD=8.04

M=14.00, SD=8.04

M=19.07, SD=11.28

M=24.00, SD=14.80

M=24.67, SD=13.50

M=11.53, SD8.04

M=14.47, SD=9.65

M=11.40, SD=11.54

M=20.40, SD=23.17

M=26.13, SD=24.78

M=19.27, SD=13.42
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Discussion
The life expectancy of adults with mental retardation
has significantly increased in recent years (Silverman et
al., 1998; Yang, Rasmussen & Friedman, 2000).

As a result,

the prevalence of age-associated diseases such as dementia
of the Alzheimer’s type has also risen (Zigman, Silverman,
& Wisniewski, 1996).

Unfortunately, accurate prevalence

rates are difficult to obtain because the evaluation and
diagnosis of dementia in persons with MR is a complicated
and involved process.

Due to these individuals’ life long

histories of cognitive impairment and the potentially
unique presentation of clinical symptoms of dementia in
this population, valid assessment of dementia in persons
with MR remains a problematic challenge.

In addition,

although an increasing number of researchers are focusing
on the aging process in persons with intellectual
disabilities, comparison of experimental results is
difficult due to the lack of uniform research methods and
clear diagnostic criteria.

This study set out to replicate

the diagnostic method proposed by Visser et al. (1997) on a
sample of 90 developmentally disabled individuals with and
without Down’s syndrome.

Prevalence rates and presenting

symptoms were compared with Visser et al. (1997) results.
Further analysis investigated the effects of age, sex,
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level of MR, syndrome, and perceived risk of dementia on
the participants’ assessment scores.
We discovered that, during the course of three years,
15 (16.7%) of our 90 participants developed symptoms of
dementia compatible with Visser et al.’s (1997) criteria.
Seven of those participants who met criteria had a comorbid diagnosis of Down’s syndrome.

These rates are very

similar to results obtained by Visser et al. (1997) that
showed that 18% of their patients with Down’s syndrome
developed symptoms of dementia.

Also consistent with the

results of Visser et al. (1997), our participants showed
greatest decline in their ability to perform coordinated
movements, as demonstrated by a poorer work performance,
greater dependence on assistance to complete daily living
skills, and onset of deterioration in their ability to
perform household chores.

We acknowledge that, without

postmortem examination, we cannot guarantee that our 15
participants were truly showing symptoms indicative of
dementia.

Visser et al. (1997) was able to provide more

diagnostic confirmation by including EEG recordings in
their screening.

Further confirmation was obtained for

Visser at al. (1997) when a marked association was noted
between their clinical diagnosis and neurological changes
in the brains of 13 patients who died during the course of
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their study.

However, because our methodology and

diagnostic criteria were similar to Visser et al.’s (1997)
study, we feel that we have successfully replicated their
results and have demonstrated that the MESSIER is an
appropriate substitute for the Social Skills Inventory for
the Mentally Retarded.
Using a differential prevalence design we were able to
compare our three risk groups (high = those referred by
caretakers, medium = individuals 55 years and older who had
not been referred, and low = individuals 40 years and
younger who had not been referred).

Results indicated that

the degree of deterioration of skills was significantly
different among the groups, with the greatest proportion of
persons demonstrating symptoms of dementia belonging to the
high risk group.

However, it should be noted that though

the Pearson chi-square statistic was significant (p=.012),
it is possible that a difference was predicted that was not
actually there.

Statisticians recommend that the chi

square test not be used if any cell has an expected
frequency of less than one or if more than 20% of the cells
have an expected frequency of less than 5.

Though our

expected frequencies were not less than one, six of our 12
cells (50%) had an expected count less than 5. Thereby our
cell frequencies were too low for chi square to be
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appropriately used.

We could have placed greater

confidence on our results if our sample size had been
larger, thereby increasing the number of individuals in
each cell.

However, because the number of individuals with

Down’s syndrome that resided in the developmental center
limited our total sample size to 90, it is suggested that
data continue to be collected on the present sample.

The

rationale for this is to determine whether our
participants’ skills continue to deteriorate and whether
the prevalence of individuals showing symptoms of dementia
increases.

The length of our study was less than a third

of Visser et al.’s (1997) 10-year study.

Three years may

not be sufficient to observe significant declines. This
will be discussed further in reference to the results of
our longitudinal analysis.
In addition to making a comparison with Visser et
al.’s (1997) study, this study was designed to examine agerelated changes in behavioral and social functioning in
individuals with and without Down’s syndrome over a three
year period.

A number of recently published studies have

established an association between Alzheimer’s dementia and
Down’s syndrome (Crayton, Oliver, Holland, Bradbury & Hall,
1998; Devenny, Krinsky-McHale, Serson, & Silverman, 2000;
Holland, Hon, Huppert & Stevens, 2000).
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Therefore, it was

hypothesized that persons with Down’s syndrome,
particularly those who had been referred for a neurological
assessment, would have higher scores on the ESDC total and
MESSIER Negative scale, as well as lower MESSIER Positive
scores than participants that did not have a co-morbid
diagnosis of Down’s syndrome.

However, our results were

inconsistent with studies that have found an accelerated
rate of decline for persons with Down’s syndrome as
compared to other individuals with mental retardation (Das,
Mishra, Davison & Naglieri, 1995; Thompson, 2003).
Significant differences between the syndrome groups were
not noted in either ESDC total or MESSIER Positive scores.
There are two possible explanations why differences between
our “syndrome” groups were not observed.

Both explanations

focus on our subjects’ level of mental retardation and how
pre-morbid cognitive deficits can effect the scores of
persons with and persons without Down’s syndrome.
One explanation for the absence of significant
differences between the “syndrome” groups is the effect of
pre-morbid deficits upon the prevalence rates of our
participants with Down’s syndrome.

In this present study,

15.5% of our Down’s syndrome sample showed symptoms of
dementia.

This is significantly lower than prevalence

rates noted in the literature (Zigman, Schupf, Haveman &
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Silverman, 1996).

For instance Holland et al. (2000) found

that approximately 60% of their participants with Down’s
syndrome developed dementia by the time they reached 60
years of age. Unlike other studies that included persons
functioning within the mild and moderate ranges of MR (Das,
Mishra, Davison & Naglieri, 1995), this present study only
contained persons with severe and profound MR.

It is

believed that declines were not as evident for our sample
because their low pre-morbid abilities made identification
of further decline very difficult.

Deterioration in skills

may have appeared small and slow because there was not
enough room for further decline.
The second, and more likely explanation considers the
effect of pre-morbid functioning upon the non-Down’s
syndrome group.

Although significantly fewer studies have

looked at dementia in persons without Down’s syndrome,
researchers have established much lower rates for this
population in comparison to prevalence rates of persons
with Down’s syndrome.

For instance, Janicki and Dalton

(2000) found that 6.1% of their adults with MR but without
Down’s syndrome were classified with dementia.

However,

more than 17% of our participants demonstrated symptoms of
dementia.

This accelerated rate may be explained by the

“Reserve Capacity Model” (Mortimer, 1988).
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The reserve

capacity model is based on research that shows that brain
cells gradually die as people age (Jorm, 1996).

However,

because most individuals have a sufficient “reserve
capacity” of brain cells to compensate for these losses,
declines in cognitive functioning are not immediately
evident.

Signs and symptoms of dementia only appear when

an excess of neurons are lost and compensation is no longer
possible (Katzman, 1993).

The reserve capacity model

states that persons who already have low levels of
cognitive abilities (and for whom initial cognitive
capacity is likely to be diminished) are at increased risk
for dementia (Snowdon, Greiner, Kemper, Nanayakkara &
Mortimer, 1999; Whalley et al., 2000).

Furthermore,

individuals with lower levels of functioning (our subjects
with severe and profound MR) are expected to experience an
earlier onset of dementia symptoms and a faster rate of
decline (Devenny et al., 1996; Temple, Joszvaki,
Konstantareas & Hewitt, 2001).

It is hypothesized that

individuals with severe and profound MR have accelerated
rates of dementia because of limited brain cell reserve.
The additional diagnosis of Down’s syndrome has little
effect on persons already functioning at these low premorbid states.
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The only difference that was noted between our
“syndrome” groups was on the MESSIER Negative scale.

We

had predicted that, consistent with previous studies
(Thompson, 1999), our Down’s syndrome group would show a
greater amount of negative social behaviors than our nonDown’s syndrome group.

However, the converse was actually

found and our non-Down’s syndrome group demonstrated more
negative behaviors.

We feel this may be related to

behavioral phenotypes that have been associated with Down’s
syndrome (Dykens & Kasari, 1997; Kasari & Freeman, 2001).
Studies have shown that individuals with Down’s syndrome
tend to be more social than individuals with MR due to
other etiologies.

For instance, Kasari and Hodapp (1996)

found that children with Down’s syndrome displayed greater
amounts of social, engaging behavior than were typically
found in other types of retardation.

These behavioral

phenotypes may persist throughout the individual’s lifespan
and make development of negative social behaviors less
likely.
These cross sectional analyses are, at best, an
indirect reflection of the differences in these samples.
Therefore caution needs to be used when interpreting these
data because of methodological limitations associated with
cross sectional studies (e.g., cohort effects and selective
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survival).

In fact, it is believed that selective survival

may have prevented us from observing the age effects that
are common in dementia studies.

Selective survival is

based on the notion that older age groups consist of a pool
of surviving subjects and these survivors may have been
individuals whose average health at age 40 was better than
those who did not survive to old age (Strauss & Zigman,
1996; Widaman et al, 1994).

This “selective survival”

effect is likely to be a problem among adults with MR who
are known to experience premature mortality (Burt et al.,
1995).

Our comparison of the medium (“old age”) and low

risk group did not result in any significant differences in
ESDC, MESSIER Positive or MESSIER Negative scores.

It is

believed that, due to selective survival, our sample of
older adults (medium risk group) may have been more fit
than our sample of younger adults (low risk group).

Thus,

our older group may have been unrepresentatively healthy
whereas it is likely that our younger group was made up of
future survivors and non-survivors.

Further evidence of

selective survival is demonstrated by the scores of our
Down’s syndrome participant who was over the age of 70.
This individual had no items endorsed on the ESDC, his
MESSIER Positive score was higher than the mean of any
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other age group, and his MESSIER Negative score was lower
than the mean of any other age group.
Researchers have long established that the preferred
design for a study of aging is a longitudinal design.

In

such a design, cohort effects would not be confounded with
age effects (Salthouse, 1982).

A repeated measure ANOVA

was used to test for significant changes in MESSIER
Positive and MESSIER Negative scores over time with the
expectation that longitudinal changes would not be evident
in the low risk group, would be evident in the medium risk
group, and would be most evident in the high risk group.
Changes in scores were noted over the three test
administrations but the rate of decline was statistically
similar across all groups regardless of their “risk of
dementia” or “syndrome” status.
The length of our longitudinal study may provide a
possible explanation why significant main effects for
“syndrome” and “risk of dementia” or significant
interaction effects for “time * syndrome” and “time * risk
of dementia” were not found.

Previous studies that have

shown differential rates were conducted for a longer
duration (e.g., Visser et al. (1997) monitored their
participants for up to 10 years).

Or, the period between

pre- and post-tests was longer (e.g., Holland and Hon
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(1996) waited 18 months before re-administering their
assessments).

Once again, it is suggested that data

continue to be collected on this sample to determine
whether the rates of decline continue to change as time
passes.
This present study had several limitations.

As

mentioned, the duration of the study may not have been long
enough and one year between test administrations may not
have been sufficient enough to see a decline in skills.
second limitation was our sample size.

A

We had difficulty

finding potential participants with Down’s syndrome who fit
our criteria (persons with severe or profound MR,
individuals between the ages of 25-40 or 55 years and
older) so this ultimately resulted in small cell sizes in
our bivariate table.

Also, because this study only

involved an institutionalized population, our results
cannot be directly projected to non-institutionalized
individuals with mental retardation.

The greatest

limitation is that we have no pathology findings for any of
our cases that show symptoms of dementia.

Therefore,

although we can hypothesize that the observed declines in
social and behavioral functioning are due to dementia, we
cannot confirm this without autopsy findings.

83

Overall, results of this study indicate that the
Visser et al. (1997) method was useful in distinguishing
between “risk of dementia” groups.

Although differences

between syndrome groups were not as large as anticipated,
valuable information was obtained regarding the signs,
symptoms and course of dementia in persons with
intellectual disabilities.

In addition, this study

provides further support that, though caregiver reports are
useful in identifying functional impairments, clinicians
should not wait for a referral before completing a dementia
assessment on an aging individual.

Though the high risk

group (those referred by caregivers) contained the largest
proportion of persons meeting Visser et al. (1997) criteria
for dementia, testing demonstrated that 10% of non-referred
individuals also showed signs of deterioration.

Therefore,

all individuals with developmental delays should undergo a
comprehensive evaluation by the age of 25 years and testing
should be repeated at least once every five years to assess
for declines in functioning (Aylward et al., 1995).
This is particularly important because assessment may
allow clinicians to detect dementia early enough stage to
to attempt to slow the individual’s cognitive decline with
medication.

Although there is no cure for dementia of the

Alzheimer’s type, there are a number of drugs available
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that have shown effective in stabilizing the symptoms of
dementia, thus improving well being and easing caregiver
burden.

The drugs that have been most widely used include

the cholinesterase inhibitors: donepezil (Aricept),
galantamine (Reminyl), and rivastigmine (Exelon) and a
glutamate blocker: memantine (Namenda). (Reisberg et al.,
2003; Winblad & Portis, 1999).
Identification of the onset of deterioration should
also influence treatment planning. Training priorities
should change once progressive delays are identified.

For

instance, the focus of treatment can be teaching these
individuals alternate modes of communicating their wants
and needs and preserving whatever intact communication
skills there are.

Social skills training may also be

beneficial but with a focus of training shifted from new
skills acquisition to current skills preservation.

This

may enhance the quality of their lives by sustaining their
ability to participate in interpersonal interactions and
thus thwart or even just postpone the course and pace of
deterioration (Walsh et al., 2001).

In addition, educating

staff members of the dementing process and providing
guidelines for caring for persons clinically diagnosed with
dementia may improve the quality of the clients’ lives and
enhance the staffs’ caregiver roles by allowing their
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attitude to change their caregiving activities as clients’
needs and abilities change (Engelman, Altus & Matthews,
1999). Thus, changing training priorities can have a
dramatic impact on the resident’s activities of daily
living and perhaps postpone their transfers to a more
restrictive mental health setting.
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